{"id":"https://openalex.org/W1547422425","doi":"https://doi.org/10.21236/ada592130","title":"Cotargeting VEGF and Neuropilins With Bevacizumab and Secreted Wnt Inhibitors in Prostate Cancer","display_name":"Cotargeting VEGF and Neuropilins With Bevacizumab and Secreted Wnt Inhibitors in Prostate Cancer","publication_year":2013,"publication_date":"2013-09-01","ids":{"openalex":"https://openalex.org/W1547422425","doi":"https://doi.org/10.21236/ada592130","mag":"1547422425"},"language":"en","primary_location":{"id":"doi:10.21236/ada592130","doi":"https://doi.org/10.21236/ada592130","is_oa":false,"landing_page_url":"https://doi.org/10.21236/ada592130","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},"volume":null,"type":"report","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036496290","display_name":"Xiaolin Zi","orcid":"https://orcid.org/0000-0002-5312-7158","observed_orcids":["https://orcid.org/0000-0002-5312-7158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaolin Zi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006286880","display_name":"Noriko N. Yokoyama","orcid":"https://orcid.org/0000-0001-7811-7303","observed_orcids":["https://orcid.org/0000-0001-7811-7303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noriko Yokoyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000907359","display_name":"Christopher Blair","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Blair Christopher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.42820000648498535,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.42820000648498535,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.35519999265670776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.13950000703334808,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8799999952316284},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.6880000233650208},{"id":"https://openalex.org/keywords/neuropilins","display_name":"neuropilins","score":0.7910000085830688},{"id":"https://openalex.org/keywords/neuropilin-2","display_name":"neuropilin-2","score":0.8650000095367432},{"id":"https://openalex.org/keywords/wif1","display_name":"WIF1","score":0.7910000085830688},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.902999997138977},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.8960000276565552},{"id":"https://openalex.org/keywords/lef1","display_name":"LEF1","score":0.7950000166893005},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6570000052452087},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.8100000023841858},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.7730000019073486},{"id":"https://openalex.org/keywords/proteolytic-cleavage-sites","display_name":"proteolytic cleavage sites","score":0.718999981880188},{"id":"https://openalex.org/keywords/cell-migration-and-invasion","display_name":"cell migration and invasion","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.7077630162239075},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.707762598991394},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6922168731689453},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.5950086712837219},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5291759371757507},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5015735626220703},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3706135153770447},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3233949542045593},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30284616351127625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29966771602630615},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2222171425819397},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21794241666793823},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19755175709724426},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1321563720703125},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.12294524908065796},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0869813859462738},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21236/ada592130","doi":"https://doi.org/10.21236/ada592130","is_oa":false,"landing_page_url":"https://doi.org/10.21236/ada592130","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2118961722","https://openalex.org/W2144215173"],"related_works":["https://openalex.org/W2323454536","https://openalex.org/W2120851921","https://openalex.org/W2159973050","https://openalex.org/W7099001070","https://openalex.org/W55200995","https://openalex.org/W4367839792","https://openalex.org/W4311098219","https://openalex.org/W2591012214","https://openalex.org/W2036449882","https://openalex.org/W1967557518"],"abstract_inverted_index":{"Abstract":[0],":":[1],"The":[2,44],"objectives":[3],"of":[4,105,123,134,139,143,159],"this":[5],"proposal":[6],"are":[7,92,98],"to":[8,25,59,101,129,178],"test":[9],"hypotheses:":[10],"1)":[11],"WIF1":[12,45],"IgG":[13,46],"fusion":[14,47,73,108],"protein":[15,48,74,109,167],"has":[16],"an":[17,79],"additive":[18],"or":[19],"synergistic":[20],"effect":[21],"with":[22,53],"anti-VEGF":[23],"therapy":[24],"inhibit":[26],"tumor":[27,154],"growth":[28,155],"and":[29,31,39,65,94,121,125,132,153,162,176],"metastasis;":[30],"2)":[32],"NRP2":[33,126,144,166],"is":[34],"a":[35],"wnt":[36],"target":[37],"gene":[38],"predicts":[40],"prostate":[41,158,173],"cancer":[42,174],"progression.":[43],"expression":[49,122,138,145],"construct":[50],"was":[51,57,75],"re-engineered":[52],"pFUSE-hIgG1-Fc":[54],"vector,":[55],"which":[56],"suggested":[58,86],"have":[60],"good":[61,66],"stability":[62],"in":[63,99,146,171],"plasma":[64],"pharmacokinetic":[67],"properties.":[68],"However,":[69],"the":[70,88,103,106,157],"produced":[71],"WIF1-Fc":[72,107],"still":[76],"cleaved":[77],"into":[78],"about":[80],"35":[81],"kd":[82],"fragment.":[83],"Bioinformatics":[84],"analysis":[85],"that":[87,116],"potential":[89],"cleavage":[90],"sites":[91],"Lys339":[93],"Arg340.":[95],"Mutagenesis":[96],"assays":[97],"progress":[100],"solve":[102],"problem":[104],"cleavage.":[110],"In":[111],"addition,":[112],"our":[113],"results":[114],"showed":[115],"Bevacizumab":[117],"increased":[118,130],"Wnt":[119],"signaling":[120],"c-Met":[124],"protein,":[127],"leading":[128],"migration":[131],"invasion":[133,152],"PC3":[135],"cells.":[136],"Ectopic":[137],"WIF1and":[140],"stable":[141],"knock-down":[142],"PC3/LN4":[147],"cells":[148],"decreased":[149],"cell":[150],"migration,":[151],"at":[156],"SCID":[160],"mice":[161],"lymph":[163],"node":[164],"metastasis.":[165],"levels":[168],"were":[169],"elevated":[170],"castration-resistant":[172],"tissues":[175],"correlate":[177],"LEF1.":[179]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}